Federal Register / Vol. 71, No. 188 / Thursday, September 28, 2006 / Notices 56993 

ESO–1/CAG–3-specific T cells to elicit 

an anti-cancer immunogenic response 

and thereby eliminating or reducing the 

cancer. While these vaccines and 

pharmaceutical compositions may be 

developed for use against a variety of 

cancers, data obtained to date indicate 

that they may be of particular value for 

use against melanoma. 

Methods for diagnosing cancer via the 

detection of NY ESO–1/CAG–3 are also 

embodied in the invention. 

Inventors: Steven A. Rosenberg (NCI) 

et al. 

Patent Status: U.S. Patent No. 

7,084,239 issued 01 Aug 2006 (HHS 

Reference No. E–265–1997/0–US–04). 

Licensing Status: Available for nonexclusive licensing or exclusive 

licensing. 

Licensing Contact: Jesse S. Kindra, 

J.D.; 301/435–5559; 

kindraj@mail.nih.gov. 

Dated: September 20, 2006. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. E6–15975 Filed 9–27–06; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Clinical Center; Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the NIH Advisory Board 

for Clinical Research, September 29, 

2006, 10 a.m. to September 29, 2006, 2 

p.m. National Institutes of Health, 

Building 10, 10 Center Drive, 4–2551, 

CRC Medical Board Room, Bethesda, 

MD 20892 which was published in the 

Federal Register on September 8, 2006, 

FR 06–7534. 

The open session will occur from 10 

a.m.–1:30 p.m. The closed session will 

begin approximately at 1:30 p.m. and 

run until 2 p.m. The meeting will be 

held in the Clinical Center, Bldg. 10, 

Rm. 4–2551, CRC Medical Board Room. 

The meeting is partially Closed to the 

public. 

Dated: September 19, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8329 Filed 9–27–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Alternative Medicine; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

application, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Basic Science. 

Date: October 23–24, 2006. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Dale L. Birkle, PhD, 

Scientific Review Administrator, Office of 

Scientific Review, National Center for 

Complementary and Alternative Medicine, 

NIH, 6707 Democracy Blvd., Suite 401, 

Bethesda, MD 20892, (301) 451–6570, 

birkled@mail.nih.gov. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Clinical Research. 

Date: October 30–31, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Jeanette M. Hosseini, PhD, 

Scientific Review Administrator, Office of 

Scientific Review, National Center for 

Complementary and Alternative Medicine, 

NIH, 6707 Democracy Blvd., Suite 401, 

Bethesda, MD 20892, (301) 594–9096, 

jeanetteh@mail.nih.gov. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Clinical Research 

Huntington’s Disease. 

Date: October 31, 2006. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Jeanette M. Hosseini, PhD, 

Scientific Review Administrator, Office of 

Scientific Review, National Center for 

Complementary and Alternative Medicine, 

NIH, 6707 Democracy Blvd., Suite 401, 

Bethesda, MD 20892, (301) 594–9096, 

jeanetteh@mail.nih.gov. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Developmental 

Centers for Research on CAM. 

Date: November 16–17, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda, Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Martina Schmidt, PhD, 

Scientific Review Administrator, Office of 

Scientific Review, National Center for 

Complementary and Alternative Medicine, 

NIH, 6707 Democracy Blvd., Suite 401, 

Bethesda, MD 20892, (301) 594–3456, 

schmidma@mail.nih.gov. 

Dated: September 19, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8328 Filed 9–27–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

wouldconstitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Tropical Medicine Research 

Centers. 

Date: October 16–18, 2006. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Gary S. Madonna, PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, National Institutes of Health/ 


sroberts on PROD1PC70 with NOTICES